Gulf crackdown on Captagon raises fears Europe will be next target

Europe is bracing for the possible influx of a drug from the Middle East as political shifts and crackdowns in the Gulf spur producers in Syria and Lebanon to tap new markets. Selling for around $3 to $25 per tablet, the amphetamine-type pill Captagon is primarily produced and trafficked by individuals and groups tied to Syrian President Bashar Al Assad and his ally the Lebanese militia Hezbollah , according to the US State Department and Treasury, the UK’s Foreign Office and independent researchers. Already popular in parts of the Middle East with everyone from teenagers to low-income construction workers, the narcotic is easy to make. Called “the poor man’s cocaine”, it’s reported to trigger bursts of energy and productivity, wakefulness, euphoria, as well as delusions and a sense of invincibility. The drug has also been associated with militants in Iraq and Syria. Two leading researchers at the think tank New Lines Institute estimate that Captagon has generated business worth as much as $10 billion over the past three years, with most of the revenue benefiting Mr Al Assad’s inner circle and allies, who remain heavily sanctioned by the West over their bloody crackdown on Syria’s 2011 uprising. Mr Al Assad and his government deny involvement in the manufacture and trade of Captagon. But now Captagon is likely to become a threat for Europe and the rest of the world too, warn officials and experts. A crackdown by Saudi Arabia, coupled with recent efforts to re-engage Mr Al Assad in order to curb flows of the drug, is spurring producers to develop new routes and markets, experts say. “Like any illicit economy, these traffickers and smugglers are becoming much more sophisticated and advanced in trying to target new transit markets, identify new routes, and then also try to carve out new consumption markets,” said Caroline Rose, a director at the New Lines Institute, where she leads a research project on the Captagon trade. “They’re adapting and adopting new methods.” Two senior European Union officials who spoke on condition of anonymity said that intelligence reports they have seen and briefings they received from counterparts in the Middle East suggest it is very likely that Captagon flows into Europe will intensify, driven by Syria’s need for cash and Mr Al Assad’s desire to export addiction and social tensions to countries that in his view harmed him. Like the US, European powers first backed popular protests against Mr Al Assad and then supported political dissidents and rebel groups that have sought to topple him. The officials, who asked not to be named because of the sensitivity of the matter, said that while Captagon has not become a problem in Europe yet, policymakers and security officials across the continent are increasingly concerned about it. In an interview with Sky News Arabia last week, Mr Al Assad said war, weak governance and corruption have turned Syria into a “flourishing” base for Captagon manufacturing and trade but denied involvement by him or his government. He said responsibility lay with western and regional states that “sowed chaos in Syria” by intervening on his opponents’ side. Europe risks experiencing the same scenario that has played out in Iraq and Turkey, according Ms Rose, noting that those two countries were popular trans-shipment points for Captagon but are now becoming destination markets. Iraqi authorities announced in early August that they had busted a key network after discovering the first Captagon factory in July. The threat, she said, is not just to countries in Europe’s periphery like Greece and Italy, where authorities seized more than 14 tonnes of Captagon in 2020, but also in the centre and north where there have been numerous Captagon warehouse raids in recent years. In 2021, Austrian investigators coordinating with counterparts on four continents broke up a transnational gang bringing in Captagon pills from Lebanon and Syria to Europe. The drug ring, which used a pizzeria in Salzburg as one of its hubs, was shipping Captagon to Saudi Arabia inside pizza ovens and washing machines. The smugglers’ rationale was that the Saudis were less likely to search cargo from Europe. As narcotics get trafficked through new routes, some intermediaries are paid in kind with the drug itself, creating the risk of spillover into the local market, according to a senior official familiar with the thinking of the United Nations Office on Drugs and Crime. The expanding scope of the Captagon trade is also alarming the US . Two US lawmakers introduced a bill in July to issue new sanctions against Mr Al Assad with one of them describing him as “a transnational drug kingpin.” In June, the Biden administration released its strategy to “disrupt, degrade, and dismantle the illicit Captagon networks linked to the Assad regime” as mandated by the Captagon Act passed last year. This year, Brussels, London and Washington imposed sanctions on Syrian and Lebanese individuals including three cousins of Mr Al Assad whom they accused of mass producing Captagon. The drug first appeared in the early 1960s in Germany as an authorised pharmaceutical under the trade name Captagon. Its main ingredient was fenethylline and it was prescribed for a range of conditions, including attention-deficit hyperactivity disorder and narcolepsy. Following the collapse of the Soviet Union, both Syria and Lebanon began to emerge as production centres in the 2000s. Production surged after a popular uprising against Mr Al Assad was brutally crushed and became a war that drew in regional and world powers and extremist groups. Gulf Arab states have been the biggest market for Captagon producers over the past two decades. More than one billion pills have been seized in the past three years with the bulk destined for Saudi Arabia, according to Karam Shaar, a Syrian economist and researcher who has advised western governments on Syria’s war economy. In last week’s interview, Mr Al Assad seemed to make the lifting of European and US sanctions on Syria and funds to rebuild the economy a precondition to any progress in fighting Captagon or allowing Syrian refugees to return homes. Mr Al Assad is deploying Captagon as a “diplomatic tool” to try to secure financial support from Saudi Arabia and sanctions relief from the West, said Lina Khatib, director of the SOAS Middle East Institute, who gave testimony to British lawmakers in June.

Gulf crackdown on Captagon raises fears Europe will be next target

Arab states have re-engaged with Syria, a key producer, in an effort to curb flows of the drug